 Our study demonstrated that the addition of O-malizumab to allergen in unotherapy, AIT, resulted in greater improvement in asthma control than AIT alone in patients with house dust mite, HDM, driven asthma. This suggests that combining AIT with anti-ig antibodies may be beneficial in improving asthma control in these patients. This article was authored by Andrei Bozek, Andreas Fischer, Agniska Bogaxpijaseksinska, and others.